Vismodegib

Por Rudin, Charles M.
Publicado em 2012

Vismodegib

Por Rudin, Charles M.
Publicado em 2012

Small-cell lung cancer in the era of immunotherapy

Por Majem, Margarita, Rudin, Charles M.
Publicado no Transl Lung Cancer Res (2017)

Youth Has No Age: Cancer Treatment for Older Americans

Por Paller, Channing J., Rudin, Charles M.
Publicado em 2010

Novel Therapeutic Approaches for Small Cell Lung Cancer: The Future has Arrived

Por Pietanza, M. Catherine, Rudin, Charles M.
Publicado em 2012

DNA Cleavage and Trp53 Differentially Affect SINE Transcription

Por Hagan, Christy R., Rudin, Charles M.
Publicado em 2007

Management of Small-Cell Lung Cancer: Incremental Changes but Hope for the Future

Por HANN, CHRISTINE L., RUDIN, CHARLES M.
Publicado em 2008

Fast, hungry and unstable: finding the Achilles’ heel of small-cell lung cancer

Por Hann, Christine L., Rudin, Charles M.
Publicado em 2007

Small Cell Lung Cancer: Where Do We Go From Here?

Por Byers, Lauren Averett, Rudin, Charles M.
Publicado no Cancer (2014)

Atezolizumab for the treatment of non-small cell lung cancer

Por Santini, Fernando C., Rudin, Charles M.
Publicado no Expert Rev Clin Pharmacol (2017)

Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small cell lung cancer

Por Rudin, Charles M., Hong, Kelvin, Streit, Michael
Publicado em 2013

RET mutations in neuroendocrine tumors – including small cell lung cancer

Por Rudin, Charles M., Drilon, Alexander, Poirier, J. T.
Publicado em 2014

Lung Cancer in Never Smokers: A Call to Action

Por Rudin, Charles M., Avila-Tang, Erika, Samet, Jonathan M.
Publicado em 2009

Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer

Por Aftab, Blake T., Dobromilskaya, Irina, Liu, Jun O., Rudin, Charles M.
Publicado em 2011

The future of epigenetic therapy in solid tumours—lessons from the past

Por Azad, Nilofer, Zahnow, Cynthia A., Rudin, Charles M., Baylin, Stephen B.
Publicado em 2013

Seneca Valley Virus 3C(pro) Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy

Por Miles, Linde A., Brennen, W. Nathaniel, Rudin, Charles M., Poirier, John T.
Publicado no PLoS One (2015)

Correction: Seneca Valley Virus 3C(pro) Substrate Optimization Yields Efficient Substrates for use in Peptide-Prodrug Therapy

Por Miles, Linde A., Brennen, W. Nathaniel, Rudin, Charles M., Poirier, John T.
Publicado no PLoS One (2015)

SVF1 Regulates Cell Survival by Affecting Sphingolipid Metabolism in Saccharomyces cerevisiae

Por Brace, Jennifer L., Lester, Robert L., Dickson, Robert C., Rudin, Charles M.
Publicado em 2007

Novel Systemic Therapies for Small Cell Lung Cancer

Por Rudin, Charles M., Hann, Christine L., Peacock, Craig D., Watkins, D. Neil
Publicado em 2008

Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?

Por Pietanza, M. Catherine, Byers, Lauren Averett, Minna, John D., Rudin, Charles M.
Publicado no Clin Cancer Res (2015)